Intravenous Iron Before Heart Surgery

Can intravenous iron reduce transfusions after heart surgery?

Anemia is common among people preparing for major cardiac procedures and can leave the body with less capacity to transport oxygen during and after surgery. Because heart operations can involve substantial blood loss, patients who begin surgery with low hemoglobin levels are more likely to receive a red blood cell transfusion. The randomized trial reported in The BMJ tested whether correcting iron deficiency intravenously before an operation could reduce that need.

The reported reduction in transfusion use is clinically important because donated blood is a limited resource and transfusions, although often lifesaving, can cause reactions, circulatory overload and other complications. The finding does not mean transfusions should be withheld when medically necessary. It instead suggests that identifying and treating reversible anemia before surgery may help more patients reach the operating room with stronger blood reserves.

How does intravenous iron support recovery from cardiac surgery?

Iron is essential for producing hemoglobin, the protein in red blood cells that carries oxygen. Surgery increases the demand for new blood-cell production, but inflammation can make it difficult for the body to absorb dietary iron or use stored iron effectively. Intravenous treatment bypasses the digestive tract and delivers iron directly into the circulation, making it useful when surgery is approaching or oral tablets are unlikely to work quickly enough.

The trial also linked intravenous iron with improved recovery outcomes, although individual benefits may depend on the cause and severity of anemia, the timing of treatment and the type of operation. Restoring iron does not correct anemia caused by every condition. Vitamin deficiencies, kidney disease, ongoing bleeding and bone-marrow disorders require different or additional treatment, so laboratory evaluation remains essential.

Should every patient with anemia receive iron before heart surgery?

Preoperative assessment may include a complete blood count and tests of iron availability, such as ferritin and transferrin saturation. Results must be interpreted alongside inflammation, kidney function and the patient’s medical history. When iron deficiency is present and there is limited time before surgery, intravenous iron may be considered as part of a broader patient blood-management plan.

Modern intravenous iron formulations are generally administered under clinical supervision because infusion reactions can occur, although serious reactions are uncommon. Patients should not start iron treatment independently, and oral supplements should not be assumed to provide the same short-term effect. Decisions should account for the urgency of surgery, potential adverse effects and whether anemia signals bleeding or another condition requiring investigation.